Axonics Inc

Axonics Inc

AXNX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.07M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Axonics IncAxonics Inc-0.8--695%0.50.3
$-0.38

Current Fair Value

135.1% downside

Overvalued by 135.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.07 Million
Enterprise Value$1.09 Million
Earnings per Share$-1.33
Beta3.3
Outstanding Shares1,000,510

Return

Return on Equity-695.46%ROE
Return on Assets-425.03%
Return on Invested Capital-588.87%

Valuation & Multiples

P/E Ratio-0.81P/E Ratio
PEG1.12PEG
Price to Sales0.54Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.49
Enterprise Value to EBIT-0.35
Enterprise Value to Net Income-1
Total Debt to Enterprise0.13
Debt to Equity0.34Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Axonics ModulationTechnologies Inc

CEO: Raymond Cohen

Axonics Insider Information FAQ

In the latest 13F quarter on Stockcircle, 8 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase for Axonics in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.